Buchumschlag

Limitations of Faecal Calprotectin in Detecting Histological Changes and Persistent Villous Atrophy in Patients With Coeliac Disease on a Gluten‐Free Diet

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Verónica Segura, Ángela Ruiz‐Carnicer, Ángeles Pizarro, Carmen González‐Naranjo, Jacobo Díaz, Cristóbal Coronel‐Rodríguez, Federico Argüelles‐Arias, Marta Garzón‐Benavides, Carolina Sousa, Isabel Comino
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	Alimentary Pharmacology & Therapeutics
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

The Association of Faecal Calprotectin Measurements With Endo‐Histological Remission in Ulcerative Colitis: A Pooled Analysis
von: Laurie‐Rose Dubé, et al.
Veröffentlicht: (2026)

Research Communication: Optimising Use of Stool Gluten Immunogenic Peptide Tests for Monitoring Adherence to Gluten‐Free Diet in Patients With Coeliac Disease
von: Juan P. Stefanolo, et al.
Veröffentlicht: (2025)

Research Communication: Teriflunomide Does Not Affect Gluten‐Specific T‐Cell Activity in Coeliac Disease—A Randomised, Placebo‐Controlled Trial
von: Louise F. Risnes, et al.
Veröffentlicht: (2025)

Letter: Supporting the Role of Enzyme Therapy in Management of Coeliac Disease
von: Finlay Macrae
Veröffentlicht: (2025)

Editorial: Coeliac Disease and Women's Reproductive Health: A Lifelong Challenge
von: C. Ciacci, et al.
Veröffentlicht: (2025)

Fistula Calprotectin as a Biomarker of Local Inflammation and Treatment Response in Perianal Fistulizing Crohn's Disease
von: Runqi Wang, et al.
Veröffentlicht: (2026)

Editorial: Endomysial Antibodies for a No‐Biopsy Diagnosis of Coeliac Disease—The Jury Is Still Out
von: Mohamed G. Shiha, et al.
Veröffentlicht: (2025)

Biopsy‐Sparing Diagnosis of Coeliac Disease Based on Endomysial Antibody Testing and Clinical Risk Assessment
von: Stiliano Maimaris, et al.
Veröffentlicht: (2025)

Editorial: Fistula Calprotectin as a Biomarker of Local Inflammation and Treatment Response in Perianal Fistulising Crohn's Disease. Authors' Reply
von: Runqi Wang, et al.
Veröffentlicht: (2026)

Editorial: Endomysial Antibodies for a No‐Biopsy Diagnosis of Coeliac Disease—The Jury Is Still out. Authors' Reply
von: Stiliano Maimaris, et al.
Veröffentlicht: (2025)

Women's Health Disorders in a Coeliac Disease Population After Diagnosis—A Nationwide Cohort Analysis
von: Rama Nanah, et al.
Veröffentlicht: (2025)

Faecal incontinence: Retentive, non‐retentive and when to suspect organic pathology
von: Carlo Di Lorenzo
Veröffentlicht: (2024)

Faecal biomarkers for diagnosis and prediction of disease course in treatment‐naïve patients with IBD
von: Maria Ling Lundström, et al.
Veröffentlicht: (2024)

Systematic Review: The Relationship Between the Faecal Microbiome and Colorectal Neoplasia in Shotgun Metagenomic Studies
von: Sarah Manning, et al.
Veröffentlicht: (2025)

Letter: Interpreting Faecal SCFA Enrichment in IBS‐D—Metabolic Signal or Transit‐Related Marker?
von: Longying Zhang, et al.
Veröffentlicht: (2026)

Review article: Faecal biomarkers for assessing small intestinal damage in coeliac disease and environmental enteropathy
von: Laura Kivelä, et al.
Veröffentlicht: (2024)

Review Article: Novel Enzyme Therapy Design for Gluten Peptide Digestion Through Exopeptidase Supplementation
von: Erin R. Bonner, et al.
Veröffentlicht: (2025)

Faecal Volatile Organic Compounds to Detect Colorectal Neoplasia in Lynch Syndrome—A Prospective Longitudinal Multicentre Study
von: Elsa L. S. A. van Liere, et al.
Veröffentlicht: (2024)

Letter: Dose and Donor Matter—Determining the Optimal Strategy for Faecal Microbiota Transplantation in Clostridioides difficile Infection. Authors' Reply
von: Sara Ellegaard Paaske, et al.
Veröffentlicht: (2026)

Impact of Clinical and Pharmacological Parameters on Faecal Microbiota Transplantation Outcome in Clostridioides difficile Infections: Results of a 5‐Year French National Survey
von: Nicolas Benech, et al.
Veröffentlicht: (2024)

Improving Clinical Outcomes of Encapsulated Faecal Microbiota Transplantation for Clostridioides difficile Infection Through Empirical Donor Selection and Optimised Dosing: A Quality Improvement Study
von: Sara Ellegaard Paaske, et al.
Veröffentlicht: (2025)

Letter: Peripheral Eosinophilia Does Not Correlate With Endoscopic and Histological Activity in Paediatric Eosinophilic Oesophagitis
von: Saverio Pochesci, et al.
Veröffentlicht: (2026)

Inflammatory Potential of the Diet and Risk of Crohn's Disease and Ulcerative Colitis
von: Antoine Meyer, et al.
Veröffentlicht: (2025)

Letter: Peripheral Eosinophilia Does Not Correlate With Endoscopic and Histological Activity in Paediatric Eosinophilic Oesophagitis. Authors' Reply
von: Pierfrancesco Visaggi, et al.
Veröffentlicht: (2026)

Letter: Critical Insights on a Nationwide Cohort Study of Inflammatory Bowel Disease, Histological Activity and Fracture Risk
von: Saad Khan, et al.
Veröffentlicht: (2024)

Letter: Inflammatory Potential of the Diet and Risk of Crohn's Disease and Ulcerative Colitis
von: Zhidong Zhou, et al.
Veröffentlicht: (2025)

Letter: Diet to Modify Risk of IBD—More Plants and Less Processed Food?
von: Alice S. Day, et al.
Veröffentlicht: (2025)

Editorial: Can We Modify the Development and Disease Course of Inflammatory Bowel Disease by Diet?
von: Joyce Wing Yan Mak
Veröffentlicht: (2025)

Review: Human Intestinal Barrier—Optimal Measurement and Effects of Diet in the Absence of Overt Inflammation or Ulceration
von: Michael Camilleri
Veröffentlicht: (2025)

Letter: Diet‐microbiome interactions in inflammatory bowel disease—Navigating towards individualised dietary strategies
von: Iris Barth, et al.
Veröffentlicht: (2024)

Editorial: Food for Thought—Addressing the Nuances of Diet and Mood When Evaluating Dietary Intervention in IBS
von: Cecilia Katzenstein, et al.
Veröffentlicht: (2024)

Meta‐analysis: Persistence of advanced therapies in the treatment of inflammatory bowel disease
von: Tsz Hong Yiu, et al.
Veröffentlicht: (2024)

Editorial: Can We Modify the Development and Disease Course of Inflammatory Bowel Disease by Diet? Author's Reply
von: Aurelien Amiot, et al.
Veröffentlicht: (2025)

Letter: Clarifying the Synergistic Mechanisms of Mediterranean Diet and Time‐Restricted Feeding in MASLD Management—Authors' Reply
von: Sofia Tsitsou, et al.
Veröffentlicht: (2025)

Letter: Rifaximin Versus Low FODMAP Diet in IBS : What the Primary Endpoint Does Not Tell Us
von: Luisa Bertin, et al.
Veröffentlicht: (2026)

Editorial: Food for Thought—Addressing the Nuances of Diet and Mood When Evaluating Dietary Intervention in IBS. Authors' Reply
von: Anthony O'Connor, et al.
Veröffentlicht: (2024)

Persistence of Symptoms of Anxiety and Depression in Inflammatory Bowel Disease: A Longitudinal Follow‐Up Study
von: Christy Riggott, et al.
Veröffentlicht: (2025)

Letter: The Persistence of Anxiety and Depression in Inflammatory Bowel Disease: A Core Phenotype Beyond Inflammatory Activity
von: Brigida Barberio, et al.
Veröffentlicht: (2026)

Persistent Binge Drinking History Associated With Advanced Liver Fibrosis and All‐Cause Mortality in MetALD
von: Zhe‐Kun Xiong, et al.
Veröffentlicht: (2025)

Editorial: Personalising the Low FODMAP Diet to Achieve Therapeutic Benefit Whilst Reducing Burden and Maintaining Dietary Diversity in Irritable Bowel Syndrome. Authors' Reply
von: E. Coss‐Adame, et al.
Veröffentlicht: (2026)